| 1.60 Data as of May 24 |  -0.03 / -1.84%Today’s Change | 1.50 Today|||52-Week Range 3.51 | -24.17% Year-to-Date |
| Previous close | 1.63 |
| Today’s open | 1.62 |
| Day’s range | 1.60 - 1.65 |
| Volume | 329,656 |
| Average volume (3 months) | 378,439 |
| Market cap | $86.8M |
| Dividend yield | -- |
| Earnings growth (last year) | -2.15% |
| Earnings growth (this year) | +1.40% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | -66.49% |
| P/E ratio | NM |
| Price/Sales | 426.28 |
| Price/Book | 4.03 |
| Today’s change | Today’s % change | |
|---|---|---|
| CPIXCumberland Pharmaceu... | +0.16 | +3.37% |
| PRANPrana Biotechnology ... | +0.10 | +4.37% |
| DRRXDURECT Corp | -0.04 | -4.15% |
| APRIApricus Biosciences ... | -0.07 | -2.64% |
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $195.0K |
| Annual profit (last year) | -$37.3M |
| Net profit margin | -19,135.90% |
Sector Health Technology |
Industry Biotechnology |
President, CEO, CFO, Treasurer & Director John G. Cooper, CPA |
Chief Operating Officer & Senior Vice President Thomas F. Miller, PhD, MBA |
Corporate headquarters Warrington, Pennsylvania |
.
